News

May 17, 2017May 21, 2020

Phase 2 Trial to Assess EP-101 Cancer Vaccine-Bavencio Combo Therapy in HER2- Breast Cancer Patients

News

EpiThany says it will test its multi-antigen vaccine EP-101 STEMVAC — in combination with the PD-L1 antibody Bavencio (avelumab) — as a neoadjuvant therapy in breast cancer patients, under a three-way agreement ... Read more

May 16, 2017May 16, 2017

Oncolytics’ Reolysin Receives FDA Fast Track Designation for Metastatic Breast Cancer

News

The U.S. Food and Drug Administration has granted fast track status to Reolysin for treating metastatic breast cancer, according to its developer, Oncolytics Biotech. Fast track accelerates the review of therapies ... Read more

May 15, 2017

Imagio Optics-and-Sound Imaging System Distinguishes Benign from Malignant Breast Tumors

News

The Imagio opto-acoustic imaging (OA/US) system does a good job of distinguishing benign from malignant breast tumors, according to a Phase 3 clinical trial. Seno Medical Instruments said its system, which combines laser ... Read more

May 12, 2017

CapeRay Wins US Patent for Dual-Mode Imaging System to Detect Breast Cancer

News

CapeRay has received a U.S. patent for its dual-mode breast imaging system, which combines X-rays and ultrasounds in a single device. It is the second patent the system has received. The first was from ... Read more

May 11, 2017May 11, 2017

FDA Approves Kisqali Femara Co-Pack to Treat Subset of Advanced Breast Cancer Patients

News

The U.S. Food and Drug Administration (FDA) has approved Novartis Oncology‘s Kisqali Femara Co-Pack for to treat postmenopausal women with hormone receptor-positive, HER2-negative (HR+/HER2-) advanced or metastatic breast cancer. The Co-Pack, which includes Kisqali ... Read more

May 10, 2017

Genetics Make Black Women More Likely to Develop and Die of Aggressive Breast Cancer Than White Women

News

The risk of developing breast cancer is similar between white and black women, but black women are 42 percent more likely to die from aggressive subtypes of the disease, according ... Read more

May 9, 2017

FDA Approves LOCalizer to Help Surgeons Find Breast Cancer Lesions for Removal

News

The U.S. Food and Drug Administration has approved Faxitron‘s LOCalizer to help surgeons locate the breast cancer lesions they will remove. Manufactured by Health Beacons, LOCalizer is a wireless radiofrequency identification device ... Read more

May 8, 2017

Regular Use of Low-Dose Aspirin May Lower Risk of Women’s Breast Cancer, Study Reports

News

Regular use of low-dose baby aspirin reduces the risk of women’s breast cancer, according to the first research to reach such a conclusion. Aspirin is already known to reduce the risk ... Read more

May 5, 2017May 5, 2017

Full Interview with Agendia’s CMO on MammaPrint 70-gene Signature Test

News

Breast Cancer News, in an email exchange, interviewed Dr. William Audeh, chief medical officer of Agendia and a breast medical oncologist with nearly 30 years of clinical practice experience, to know more ... Read more

May 5, 2017May 8, 2017

MammaPrint Genomic Test Helps Early Stage Cancer Patients Safely Avoid Chemo, Agendia’s CMO Says

News

A genomic test, evaluated in several clinical trials and approved for use in the U.S. and Europe, can effectively tell early stage breast cancer patients what is their risk of cancer returning. ... Read more